MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

NCT06022341 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myeloproliferative Neoplasm
Secondary Leukemia

Interventions

OTHER: Multiomic characterization
OTHER: In vitro drug screening

Sponsor

University Hospital, Angers

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]